nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—bone cancer	0.779	1	CbGaD
Esomeprazole—Pantoprazole—CYP3A4—bone cancer	0.00159	0.281	CrCbGaD
Esomeprazole—Rabeprazole—CYP3A4—bone cancer	0.00159	0.281	CrCbGaD
Esomeprazole—Omeprazole—CYP3A4—bone cancer	0.0013	0.229	CrCbGaD
Esomeprazole—Lansoprazole—CYP3A4—bone cancer	0.00119	0.209	CrCbGaD
Esomeprazole—Neutropenia—Doxorubicin—bone cancer	0.00026	0.0012	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000258	0.0012	CcSEcCtD
Esomeprazole—Hepatitis—Methotrexate—bone cancer	0.000257	0.00119	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—bone cancer	0.000257	0.00119	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—bone cancer	0.000255	0.00118	CcSEcCtD
Esomeprazole—Pharyngitis—Methotrexate—bone cancer	0.000255	0.00118	CcSEcCtD
Esomeprazole—Urinary tract disorder—Methotrexate—bone cancer	0.000254	0.00118	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—bone cancer	0.000254	0.00118	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—bone cancer	0.000253	0.00117	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—bone cancer	0.000253	0.00117	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—bone cancer	0.000253	0.00117	CcSEcCtD
Esomeprazole—Urethral disorder—Methotrexate—bone cancer	0.000252	0.00117	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—bone cancer	0.000251	0.00116	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—bone cancer	0.000251	0.00116	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—bone cancer	0.00025	0.00116	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—bone cancer	0.000248	0.00115	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—bone cancer	0.000248	0.00115	CcSEcCtD
Esomeprazole—Visual impairment—Methotrexate—bone cancer	0.000248	0.00115	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000246	0.00114	CcSEcCtD
Esomeprazole—Hypersensitivity—Cisplatin—bone cancer	0.000245	0.00114	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—bone cancer	0.000245	0.00113	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—bone cancer	0.000244	0.00113	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—bone cancer	0.000243	0.00113	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—bone cancer	0.000242	0.00112	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—bone cancer	0.000242	0.00112	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—bone cancer	0.000241	0.00112	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—bone cancer	0.000241	0.00112	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—bone cancer	0.000241	0.00112	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—bone cancer	0.00024	0.00111	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—bone cancer	0.00024	0.00111	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—bone cancer	0.000239	0.00111	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—bone cancer	0.000239	0.00111	CcSEcCtD
Esomeprazole—Asthenia—Cisplatin—bone cancer	0.000239	0.00111	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—bone cancer	0.000239	0.00111	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—bone cancer	0.000237	0.0011	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—bone cancer	0.000237	0.0011	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—bone cancer	0.000236	0.00109	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—bone cancer	0.000236	0.00109	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—bone cancer	0.000236	0.00109	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000234	0.00109	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—bone cancer	0.000234	0.00108	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—bone cancer	0.000232	0.00108	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—bone cancer	0.000232	0.00108	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—bone cancer	0.000232	0.00107	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—bone cancer	0.000231	0.00107	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—bone cancer	0.000231	0.00107	CcSEcCtD
Esomeprazole—Chills—Methotrexate—bone cancer	0.00023	0.00107	CcSEcCtD
Esomeprazole—Diarrhoea—Cisplatin—bone cancer	0.000228	0.00105	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—bone cancer	0.000227	0.00105	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—bone cancer	0.000227	0.00105	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—bone cancer	0.000226	0.00105	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—bone cancer	0.000225	0.00104	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—bone cancer	0.000225	0.00104	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—bone cancer	0.000224	0.00104	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—bone cancer	0.000224	0.00104	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—bone cancer	0.000223	0.00103	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—bone cancer	0.000223	0.00103	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—bone cancer	0.000222	0.00103	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—bone cancer	0.000221	0.00103	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—bone cancer	0.000221	0.00102	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—bone cancer	0.00022	0.00102	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—bone cancer	0.000219	0.00102	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—bone cancer	0.000219	0.00101	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—bone cancer	0.000219	0.00101	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—bone cancer	0.000218	0.00101	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—bone cancer	0.000217	0.00101	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—bone cancer	0.000217	0.001	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—bone cancer	0.000216	0.001	CcSEcCtD
Esomeprazole—Chills—Epirubicin—bone cancer	0.000216	0.000999	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—bone cancer	0.000214	0.000993	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—bone cancer	0.000212	0.000984	CcSEcCtD
Esomeprazole—Vomiting—Cisplatin—bone cancer	0.000211	0.00098	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—bone cancer	0.000211	0.000976	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—bone cancer	0.000211	0.000976	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—bone cancer	0.00021	0.000974	CcSEcCtD
Esomeprazole—Rash—Cisplatin—bone cancer	0.00021	0.000972	CcSEcCtD
Esomeprazole—Dermatitis—Cisplatin—bone cancer	0.000209	0.000971	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—bone cancer	0.000209	0.00097	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—bone cancer	0.000208	0.000963	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—bone cancer	0.000207	0.000961	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—bone cancer	0.000207	0.000961	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—bone cancer	0.000207	0.000958	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—bone cancer	0.000206	0.000956	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—bone cancer	0.000206	0.000955	CcSEcCtD
Esomeprazole—Tension—Epirubicin—bone cancer	0.000205	0.000951	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—bone cancer	0.000205	0.000949	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—bone cancer	0.000203	0.000942	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—bone cancer	0.000202	0.000938	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—bone cancer	0.000202	0.000934	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—bone cancer	0.000201	0.000932	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—bone cancer	0.000201	0.000931	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—bone cancer	0.000201	0.000931	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—bone cancer	0.0002	0.000929	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—bone cancer	0.0002	0.000927	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—bone cancer	0.0002	0.000925	CcSEcCtD
Esomeprazole—Nausea—Cisplatin—bone cancer	0.000198	0.000915	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—bone cancer	0.000197	0.000914	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—bone cancer	0.000197	0.000911	CcSEcCtD
Esomeprazole—Cough—Methotrexate—bone cancer	0.000195	0.000904	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—bone cancer	0.000195	0.000903	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—bone cancer	0.000194	0.0009	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—bone cancer	0.000194	0.000897	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—bone cancer	0.000193	0.000896	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—bone cancer	0.000192	0.000891	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—bone cancer	0.000191	0.000884	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—bone cancer	0.00019	0.000882	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—bone cancer	0.00019	0.000882	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—bone cancer	0.00019	0.000882	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—bone cancer	0.00019	0.00088	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—bone cancer	0.00019	0.000879	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000189	0.000876	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—bone cancer	0.000189	0.000874	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—bone cancer	0.000188	0.000871	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—bone cancer	0.000188	0.000871	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—bone cancer	0.000188	0.000871	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—bone cancer	0.000187	0.000868	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—bone cancer	0.000187	0.000868	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—bone cancer	0.000186	0.000863	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—bone cancer	0.000185	0.000857	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—bone cancer	0.000184	0.000853	CcSEcCtD
Esomeprazole—Cough—Epirubicin—bone cancer	0.000183	0.000846	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—bone cancer	0.000182	0.000846	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—bone cancer	0.000182	0.000845	CcSEcCtD
Esomeprazole—Infection—Methotrexate—bone cancer	0.000181	0.00084	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—bone cancer	0.000181	0.000837	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—bone cancer	0.00018	0.000832	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—bone cancer	0.000179	0.000829	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—bone cancer	0.000179	0.000829	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—bone cancer	0.000179	0.000828	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—bone cancer	0.000178	0.000825	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—bone cancer	0.000178	0.000825	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—bone cancer	0.000178	0.000825	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—bone cancer	0.000178	0.000824	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—bone cancer	0.000178	0.000823	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—bone cancer	0.000177	0.000821	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000177	0.00082	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—bone cancer	0.000176	0.000817	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—bone cancer	0.000176	0.000816	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—bone cancer	0.000175	0.000809	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—bone cancer	0.000174	0.000807	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—bone cancer	0.000174	0.000806	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—bone cancer	0.000174	0.000806	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—bone cancer	0.000173	0.000803	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—bone cancer	0.000172	0.000798	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—bone cancer	0.000171	0.000793	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—bone cancer	0.000171	0.000791	CcSEcCtD
Esomeprazole—Infection—Epirubicin—bone cancer	0.00017	0.000786	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—bone cancer	0.000169	0.000783	CcSEcCtD
Esomeprazole—Shock—Epirubicin—bone cancer	0.000168	0.000779	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—bone cancer	0.000167	0.000776	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—bone cancer	0.000167	0.000775	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—bone cancer	0.000167	0.000775	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—bone cancer	0.000167	0.000772	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000166	0.00077	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—bone cancer	0.000166	0.000769	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—bone cancer	0.000165	0.000765	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—bone cancer	0.000165	0.000765	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—bone cancer	0.000165	0.000764	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—bone cancer	0.000165	0.000764	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—bone cancer	0.000165	0.000764	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—bone cancer	0.000164	0.000761	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—bone cancer	0.000164	0.000759	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000164	0.000759	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—bone cancer	0.000163	0.000755	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—bone cancer	0.000163	0.000754	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—bone cancer	0.000163	0.000754	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—bone cancer	0.000162	0.000752	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—bone cancer	0.000161	0.000747	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—bone cancer	0.000161	0.000744	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—bone cancer	0.000159	0.000738	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—bone cancer	0.000159	0.000735	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—bone cancer	0.000158	0.000732	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000158	0.00073	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—bone cancer	0.000157	0.000729	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—bone cancer	0.000157	0.000727	CcSEcCtD
Esomeprazole—Pain—Methotrexate—bone cancer	0.000156	0.000723	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000156	0.000721	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—bone cancer	0.000155	0.00072	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—bone cancer	0.000155	0.000718	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000155	0.000717	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—bone cancer	0.000154	0.000716	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—bone cancer	0.000154	0.000715	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—bone cancer	0.000153	0.000711	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—bone cancer	0.000153	0.000711	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000153	0.000708	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—bone cancer	0.000152	0.000705	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—bone cancer	0.000152	0.000703	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—bone cancer	0.000151	0.000698	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—bone cancer	0.00015	0.000697	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—bone cancer	0.00015	0.000697	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—bone cancer	0.000149	0.000691	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—bone cancer	0.000148	0.000688	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000147	0.000683	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—bone cancer	0.000147	0.000682	CcSEcCtD
Esomeprazole—Pain—Epirubicin—bone cancer	0.000146	0.000677	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—bone cancer	0.000146	0.000677	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—bone cancer	0.000145	0.000672	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—bone cancer	0.000144	0.000668	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—bone cancer	0.000144	0.000668	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000144	0.000667	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—bone cancer	0.000143	0.000662	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—bone cancer	0.000142	0.000657	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—bone cancer	0.000141	0.000653	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—bone cancer	0.000141	0.000652	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—bone cancer	0.00014	0.000651	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—bone cancer	0.00014	0.000647	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—bone cancer	0.000139	0.000645	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—bone cancer	0.000137	0.000636	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000136	0.000632	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—bone cancer	0.000136	0.000631	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—bone cancer	0.000136	0.000629	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—bone cancer	0.000135	0.000626	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—bone cancer	0.000135	0.000626	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—bone cancer	0.000135	0.000626	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—bone cancer	0.000135	0.000626	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—bone cancer	0.000134	0.000623	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—bone cancer	0.000131	0.000607	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—bone cancer	0.00013	0.000603	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000129	0.000599	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—bone cancer	0.000129	0.000598	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—bone cancer	0.000126	0.000583	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—bone cancer	0.000126	0.000582	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—bone cancer	0.000125	0.000579	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—bone cancer	0.000125	0.000579	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—bone cancer	0.000125	0.000579	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—bone cancer	0.000123	0.000568	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—bone cancer	0.000121	0.00056	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—bone cancer	0.000121	0.000559	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—bone cancer	0.000117	0.000541	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—bone cancer	0.000116	0.000539	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—bone cancer	0.000116	0.000538	CcSEcCtD
Esomeprazole—Rash—Methotrexate—bone cancer	0.000115	0.000533	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—bone cancer	0.000115	0.000533	CcSEcCtD
Esomeprazole—Headache—Methotrexate—bone cancer	0.000114	0.00053	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—bone cancer	0.000113	0.000525	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—bone cancer	0.000113	0.000523	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—bone cancer	0.000112	0.000518	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—bone cancer	0.000109	0.000503	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—bone cancer	0.000108	0.000502	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—bone cancer	0.000108	0.000501	CcSEcCtD
Esomeprazole—Rash—Epirubicin—bone cancer	0.000108	0.000499	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—bone cancer	0.000108	0.000498	CcSEcCtD
Esomeprazole—Headache—Epirubicin—bone cancer	0.000107	0.000496	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—bone cancer	0.000104	0.000484	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—bone cancer	0.000101	0.00047	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—bone cancer	0.0001	0.000466	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—bone cancer	9.96e-05	0.000462	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—bone cancer	9.95e-05	0.000461	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—bone cancer	9.9e-05	0.000459	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—bone cancer	9.39e-05	0.000435	CcSEcCtD
